+95-1-3592223, +95-1-3592224, +95-1-3592124, +95-1-3592125 (Ext. 320, 245)
contact.pmi@pacific-aa.com
logo-img logo-img
  • Home
  • Products
  • Factory
  • About Us
    • Introduction
    • Managing Director's Message
    • Vision & Mission
    • Milestones
    • Certificate
    • News and Media
    • CSR
  • Contact
logo-img
  • Introduction
  • Managing Director's Message
  • Vision & Mission
  • Milestones
  • Certificate

Vision 2025

ISO compliance, WHO and USFDA approval of the multi-product generic facility with 3 ANDAs focused on Myanmar and targeting Global market with a value turnover of 30 Million USD by 2025.

Mission

  • PMI is the pioneer in Myanmar pharmaceutical manufacturing of quality branded and generic drugs supported by innovations from a strong R&D team.
  • We take pride in our cGMP compliant facility with necessary infrastructure and experienced technical personnel to manufacture products of reliable quality at afforadable price.
  • With the support of our management team, affiliated marketing team, operational excellence and strong industry network, we strive to provide customer satisfaction to meet unmet market needs: making pharmaceuticals, nutraceuticals and OTC products accessible to the Myanmar and global market.

Excellence

  • Quality and Safety
  • Operational
  • Continuous improvement
  • Learning culture

Integrity

  • Transparency
  • Honesty

Strategic

  • Result oriented
  • Doing best you can

Customer service

  • Commitment to timeline

Team building

  • Coaching
  • Mentoring
  • Building leaders
  • Dedication
  • Motivation
Address

209/210/211, Corner of Kannar St. & Khun Act Thar Minthar St., City of Industry, Dagon Seikkan Township, Yangon Myanmar.

Call Us On

+95-1-3592223, +95-1-3592224, +95-1-3592124, +95-1-3592125 (Ext. 320, 245)

Email Us

contact.pmi@pacific-aa.com

On July 23, 2017, we celebrated the official opening of Pacific Medical Industries Ltd (PMI) new US $20 million manufacturing facility in Yangon, a symbol of progress for the entire nation.

Read More!

Useful Links

  • About Us
  • Contact Us
  • News Room
  • CSR
  • Products
  • Milestone

Recent Posts

  • Myanmar’s first ever locally manufactured drug for Covid-19 Pandemic: “FAVIPAC (Favipiravir 200mg), COVID-19 treatment (oral tablets) Jan 25, 2021 Myanmar’s first ever locally manufactured drug for...
  • Pacific Alpine Myanmar (a member of Pacific-AA Group) received "2019 AMCHAM CSR Excellence (ACE) Award" Dec 26, 2020 Pacific Alpine Myanmar (a member of Pacific-AA Gro...
Copyright © 2025 PMI. Powered by Mega Myanmar Link